Open Access
| Issue |
Med Sci (Paris)
Volume 42, Number 1, Janvier 2026
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 108 - 108 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2025200 | |
| Published online | 23 January 2026 | |
- Ogulur I, Mitamura Y, Yazici D, et al. Type 2 immunity in allergic diseases. Cell. Mol. Immunol. 2025 ; 22 : 211–242. [Google Scholar]
- Varricchi G, Poto R, Criscuolo G, et al. TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders. J. Allergy Clin. Immunol. 2025 ; 155 : 1420–1434. [Google Scholar]
- Schmitt P, Duval A, Camus M, et al. TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation. J. Exp. Med. 2024 ; 221 : e20231236. [Google Scholar]
- Brusselle GG, Koppelman GH. Biologic Therapies for Severe Asthma. N. Engl. J. Med. 2022 ; 386 : 157–171. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.